Results 41 to 50 of about 36,684 (227)

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.

open access: yes, 2014
INTRODUCTION: The aim of the study was to investigate predictors of mortality in patients hospitalized with hyperkalemia. MATERIAL AND METHODS: Data among hospitalized patients with hyperkalemia (serum potassium ≥ 5.1 mEq/l) were collected. Patients with
Aronow, Wilbert S   +7 more
core   +2 more sources

Prevalence of Hyperkalemia in a Contemporary European Cohort According to EKFC eGFR Categories

open access: yesDiagnostics
Background/Objectives: Hyperkalemia is common in patients with chronic kidney disease (CKD). However, its epidemiology may be evolving due to population aging, new therapeutic developments and novel estimated glomerular filtration rate (eGFR) equations ...
Priscila Villalvazo   +3 more
doaj   +1 more source

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options

open access: yesFrontiers in Medicine, 2021
Hyperkalemia is one of the main electrolyte disorders in patients with chronic kidney disease (CKD). The prevalence of hyperkalemia increases as the Glomerular Filtration Rate (GFR) declines.
Enrique Morales   +5 more
doaj   +1 more source

Drug Repurposing for Treating NCOR‐Related Intellectual Disability

open access: yesAdvanced Science, EarlyView.
An autism‐associated NCOR1 heterozygous mutation upregulates NRGs and activates NRG backward signaling in hypothalamic GABAergic neurons in mouse models, leading to Gabra2 downregulation and cognitive deficits, which can be therapeutically targeted by repurposing FDA‐approved drugs.
Yan Kong   +15 more
wiley   +1 more source

Initial and Recurrent Hyperkalemia Events in Patients With CKD in Older Adults: A Population-Based Cohort Study

open access: yesCanadian Journal of Kidney Health and Disease, 2021
Background: The risk of hyperkalemia is elevated in chronic kidney disease (CKD); however, the initial and recurrent risk among older individuals is less clear.
Sriram Sriperumbuduri   +10 more
doaj   +1 more source

Prescriber hyperkalemia knowledge regarding therapeutic decisions related to 10 hyperkalemia-related drugs, as determined by questionnaire.

open access: yes, 2013
Prescriber hyperkalemia knowledge regarding therapeutic decisions related to 10 hyperkalemia-related drugs, as determined by questionnaire.
Man Young Park (469194)   +5 more
core   +1 more source

Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring [PDF]

open access: yes, 2010
Renin-angiotensin-aldosterone system (RAAS) inhibitors are associated with hyperkalemia, but there is little evidence demonstrating patients who receive potassium monitoring have a lower rate of ...
Ross, Colleen   +7 more
core   +1 more source

Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities

open access: yesAGING MEDICINE, EarlyView.
Mineralocorticoid receptor (MR) overactivation drives inflammation, oxidative stress, and fibrosis in the heart, kidneys, and vasculature, leading to cardiorenal dysfunction. MR signaling promotes hypertrophy, remodeling, and injury through pathways like oxidative stress and inflammation, resulting in vascular stiffness and progressive organ damage ...
Xiaoming Wang, Cuntai Zhang
wiley   +1 more source

Frequency and predictors of hyperkalemia in the heart failure outpatient clinic

open access: yesActa Medica Alanya, 2022
Aim: Hyperkalemia is a common and potentially life-threatening problem in heart failure (HF). In this study, we aimed to show the frequency of hyperkalemia and related factors in the HF outpatient clinic with real-life data.Methods: 1 146 patients ...
Şakir Arslan   +4 more
doaj   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy